Samjin Pharmaceutical Co Ltd banner
S

Samjin Pharmaceutical Co Ltd
KRX:005500

Watchlist Manager
Samjin Pharmaceutical Co Ltd
KRX:005500
Watchlist
Price: 18 620 KRW 0.98% Market Closed
Market Cap: ₩233.3B

Samjin Pharmaceutical Co Ltd
Research & Development

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Samjin Pharmaceutical Co Ltd
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
S
Samjin Pharmaceutical Co Ltd
KRX:005500
Research & Development
-₩9.1B
CAGR 3-Years
7%
CAGR 5-Years
-5%
CAGR 10-Years
0%
Yuhan Corp
KRX:000100
Research & Development
-₩198.2B
CAGR 3-Years
-23%
CAGR 5-Years
-7%
CAGR 10-Years
-18%
SK Biopharmaceuticals Co Ltd
KRX:326030
Research & Development
-₩169.7B
CAGR 3-Years
-12%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Research & Development
-₩195.8B
CAGR 3-Years
-8%
CAGR 5-Years
2%
CAGR 10-Years
-2%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Research & Development
-₩8.7B
CAGR 3-Years
-8%
CAGR 5-Years
17%
CAGR 10-Years
-9%
C
Caregen Co Ltd
KOSDAQ:214370
Research & Development
-₩5.7B
CAGR 3-Years
3%
CAGR 5-Years
-5%
CAGR 10-Years
N/A
No Stocks Found

Samjin Pharmaceutical Co Ltd
Glance View

Market Cap
233.3B KRW
Industry
Pharmaceuticals

Samjin Pharmaceutical Co., Ltd. engages in the manufacture, distribution, and sale of pharmaceutical products. The company is headquartered in Seoul, Seoul and currently employs 755 full-time employees. The Company’s products include antipyretics, analgesics, antiphlogistic agents, osteoarthritis agents, osteopathic agents, antihistaminic agents, circulatory system drugs, gastrointestinal agents, osteoporosis treatments, hepatic disease agents, respiratory agents, antibiotics agents, detoxifying agents, antifungal agents, antineoplastic agents and others. Its products are provided in the forms of tablets, injections, capsules and others. The company distributes its products to the hospitals and drugstores. The firm supplies its products within domestic market and to overseas markets.

Intrinsic Value
28 516.58 KRW
Undervaluation 35%
Intrinsic Value
Price ₩18 620
S

See Also

What is Samjin Pharmaceutical Co Ltd's Research & Development?
Research & Development
-9.1B KRW

Based on the financial report for Sep 30, 2025, Samjin Pharmaceutical Co Ltd's Research & Development amounts to -9.1B KRW.

What is Samjin Pharmaceutical Co Ltd's Research & Development growth rate?
Research & Development CAGR 10Y
0%

Over the last year, the Research & Development growth was -10%. The average annual Research & Development growth rates for Samjin Pharmaceutical Co Ltd have been 7% over the past three years , -5% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett